Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y. Ng, Raphael Koch, Neekesh V. Dharia et al.|Nature Communications|2018Cited by 114
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphomaClaudia Pignataro, Danilo Fiore|Blood Advances|2025Cited by 2